# The Vascular Biology of Dipyridamole in Peripheral Arterial Disease (PAD)

> **NCT00906035** · NA · TERMINATED · sponsor: **University of Pennsylvania** · enrollment: 25 (actual)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DRUG:** Dipyridamole 200mg and Aspirin 25mg bid:
- **DRUG:** Dipyridamole 200 mg bid
- **DRUG:** Aspirin 25 mg bid

## Key facts

- **NCT ID:** NCT00906035
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-09
- **Primary completion:** 2010-03
- **Final completion:** 2010-04
- **Target enrollment:** 25 (ACTUAL)
- **Why stopped:** Could not enroll subjects who met the stringent inclusion/exclusion criteria.
- **Last updated:** 2017-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00906035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00906035, "The Vascular Biology of Dipyridamole in Peripheral Arterial Disease (PAD)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00906035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*